In a report released today, Luke Sergott from Barclays maintained a Hold rating on Certara (CERT – Research Report), with a price target of $11.00. The company’s shares closed yesterday at $9.73.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Sergott is an analyst with an average return of -11.5% and a 30.15% success rate. Sergott covers the Healthcare sector, focusing on stocks such as Sotera Health, Illumina, and Waters.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Certara with a $13.79 average price target, implying a 41.73% upside from current levels. In a report released on April 8, Robert W. Baird also maintained a Hold rating on the stock with a $9.00 price target.
The company has a one-year high of $18.68 and a one-year low of $8.64. Currently, Certara has an average volume of 1.48M.
Read More on CERT: